These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 31831046)

  • 41. Drebrin in Alzheimer's Disease.
    Ishizuka Y; Hanamura K
    Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
    Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D.
    Penazzi L; Tackenberg C; Ghori A; Golovyashkina N; Niewidok B; Selle K; Ballatore C; Smith AB; Bakota L; Brandt R
    Neuropharmacology; 2016 Jun; 105():84-95. PubMed ID: 26772969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
    Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
    Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyloid plaque formation precedes dendritic spine loss.
    Bittner T; Burgold S; Dorostkar MM; Fuhrmann M; Wegenast-Braun BM; Schmidt B; Kretzschmar H; Herms J
    Acta Neuropathol; 2012 Dec; 124(6):797-807. PubMed ID: 22993126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
    Freund RK; Gibson ES; Potter H; Dell'Acqua ML
    Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
    J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.
    de Pins B; Cifuentes-Díaz C; Farah AT; López-Molina L; Montalban E; Sancho-Balsells A; López A; Ginés S; Delgado-García JM; Alberch J; Gruart A; Girault JA; Giralt A
    J Neurosci; 2019 Mar; 39(13):2441-2458. PubMed ID: 30700530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.
    Huang L; Lan J; Tang J; Kang Y; Feng X; Wu L; Peng Y
    Mol Neurobiol; 2021 Mar; 58(3):1260-1274. PubMed ID: 33146400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease.
    Liu LZ; Fan SJ; Gao JX; Li WB; Xian XH
    Brain Res Bull; 2023 Aug; 200():110683. PubMed ID: 37301482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
    Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
    Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.
    Zhang H; Sun S; Wu L; Pchitskaya E; Zakharova O; Fon Tacer K; Bezprozvanny I
    J Neurosci; 2016 Nov; 36(47):11837-11850. PubMed ID: 27881772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
    Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
    Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    Martins IV; Rivers-Auty J; Allan SM; Lawrence CB
    J Alzheimers Dis; 2017; 55(3):915-932. PubMed ID: 27802235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The upside of APP at synapses.
    Hoe HS; Lee HK; Pak DT
    CNS Neurosci Ther; 2012 Jan; 18(1):47-56. PubMed ID: 21199446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of EphA4 in axon terminals and dendritic spines of adult rat hippocampus.
    Tremblay ME; Riad M; Bouvier D; Murai KK; Pasquale EB; Descarries L; Doucet G
    J Comp Neurol; 2007 Apr; 501(5):691-702. PubMed ID: 17299751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation.
    Inoue E; Deguchi-Tawarada M; Togawa A; Matsui C; Arita K; Katahira-Tayama S; Sato T; Yamauchi E; Oda Y; Takai Y
    J Cell Biol; 2009 May; 185(3):551-64. PubMed ID: 19414612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease.
    McIntire LB; Berman DE; Myaeng J; Staniszewski A; Arancio O; Di Paolo G; Kim TW
    J Neurosci; 2012 Oct; 32(44):15271-6. PubMed ID: 23115165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.